Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Hagemann

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Neuro-Signals|November 29, 2019
The Acid Sphingomyelinase/ Ceramide System as Target for Ischemic Stroke TherapiesAyan Mohamud Yusuf, Nina Hagemann, Dirk M Hermann
The Science of the Total Environment|May 9, 2018
Market potential of nanoremediation in Europe - Market drivers and interventions identified in a deliberative scenario approachStephan Bartke, Nina Hagemann, Nicola Harries, et al.
Small Gtpases|July 14, 2012
Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1/Rab8 module for Lowe syndromeNina Hagemann, Xiaomin Hou, Roger S Goody, et al.
Frontiers in Immunology|January 28, 2022
Roles of Polymorphonuclear Neutrophils in Ischemic Brain Injury and Post-Ischemic Brain RemodelingAyan Mohamud Yusuf, Nina Hagemann, Peter Ludewig, et al.
Cardiovascular Research|September 10, 2013
SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradationFengyan Jin, Nina Hagemann, Simon T Schäfer, et al.
Angiogenesis|February 23, 2013
LDL attenuates VEGF-induced angiogenesis via mechanisms involving VEGFR2 internalization and degradation following endosome-trans-Golgi network traffickingFengyan Jin, Nina Hagemann, Ulf Brockmeier, et al.
Neurobiology of Disease|September 27, 2024
Signaling roles of sphingolipids in the ischemic brain and their potential utility as therapeutic targetsAyan Mohamud Yusuf, Xiaoni Zhang, Erich Gulbins, et al.
The EMBO Journal|March 8, 2011
A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1Xiaomin Hou, Nina Hagemann, Stefan Schoebel, et al.
Angiogenesis|February 17, 2018
High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activationFengyan Jin, Nina Hagemann, Li Sun, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cellsAnil Zechariah, Ayman ElAli, Nina Hagemann, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Neuro-Signals|November 29, 2019
The Acid Sphingomyelinase/ Ceramide System as Target for Ischemic Stroke TherapiesAyan Mohamud Yusuf, Nina Hagemann, Dirk M Hermann
The Science of the Total Environment|May 9, 2018
Market potential of nanoremediation in Europe - Market drivers and interventions identified in a deliberative scenario approachStephan Bartke, Nina Hagemann, Nicola Harries, et al.
Small Gtpases|July 14, 2012
Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1/Rab8 module for Lowe syndromeNina Hagemann, Xiaomin Hou, Roger S Goody, et al.
Frontiers in Immunology|January 28, 2022
Roles of Polymorphonuclear Neutrophils in Ischemic Brain Injury and Post-Ischemic Brain RemodelingAyan Mohamud Yusuf, Nina Hagemann, Peter Ludewig, et al.
Cardiovascular Research|September 10, 2013
SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradationFengyan Jin, Nina Hagemann, Simon T Schäfer, et al.
Angiogenesis|February 23, 2013
LDL attenuates VEGF-induced angiogenesis via mechanisms involving VEGFR2 internalization and degradation following endosome-trans-Golgi network traffickingFengyan Jin, Nina Hagemann, Ulf Brockmeier, et al.
Neurobiology of Disease|September 27, 2024
Signaling roles of sphingolipids in the ischemic brain and their potential utility as therapeutic targetsAyan Mohamud Yusuf, Xiaoni Zhang, Erich Gulbins, et al.
The EMBO Journal|March 8, 2011
A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1Xiaomin Hou, Nina Hagemann, Stefan Schoebel, et al.
Angiogenesis|February 17, 2018
High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activationFengyan Jin, Nina Hagemann, Li Sun, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cellsAnil Zechariah, Ayman ElAli, Nina Hagemann, et al.
Pageof 4